Swiss Semiconductors Stock News

Why the Bichsel decision matters for Galenica shareholders Galenica (SWX:GALE) has launched a consultation process on a planned production closure at its Bichsel subsidiary, a move that could affect up to 170 jobs by the end of 2026. The company plans to support affected employees with financial assistance, career guidance, and potential alternative roles within the wider Galenica network. A final decision is expected after the consultation concludes in mid March 2026. See our latest analysis...

Sandoz Group (SWX:SDZ) just packed several developments into one week, combining full year 2025 results, fresh 2026 net sales guidance, a higher annual dividend, and new EU marketing authorization for its eye drug Ranluspec. See our latest analysis for Sandoz Group. The recent mix of higher 2025 sales and net income, fresh 2026 net sales guidance, a larger dividend and Ranluspec approval comes after a 1-day share price return of a 1.82% decline and a 7-day share price return of a 6.67%...

SGS collaboration with Exterra puts sustainable mining in focus SGS (SWX:SGSN) has entered a long-term collaboration with Exterra Technologies to test on-site regeneration of chemical inputs in mineral production, aiming to cut reagent costs and reduce environmental impact. See our latest analysis for SGS. While SGS shares have eased in the short term, with a 7 day share price return of 4.02% decline and a 30 day share price return of 2.37% decline, the 1 year total shareholder return of...

Idorsia (SWX:IDIA) is back on watch for investors after a recent stretch of weak share performance, with the stock showing negative moves over the past week, month and past 3 months. See our latest analysis for Idorsia. At a share price of CHF3.53, Idorsia’s recent share price returns show pressure in the short term, including a 1 day decline of 3.55% and a year to date drop of 13.05%. In contrast, the 1 year total shareholder return of just over 3x and the deeply negative 3 and 5 year total...

Earnings and dividend move naturenergie holding (SWX:NEAG) into focus Naturenergie holding (SWX:NEAG) has drawn fresh attention after reporting its 2025 results, showing higher net income and earnings per share despite lower sales and revenue, alongside confirming an annual dividend of CHF 0.90 per share. See our latest analysis for naturenergie holding. At a share price of CHF 32.80, naturenergie holding has seen a 1 day share price return of 1.55% and a 7 day share price return of 1.23%,...

Earnings jump and lower dividend put HIAG Immobilien Holding (SWX:HIAG) in focus HIAG Immobilien Holding (SWX:HIAG) is back on investors’ radar after releasing full year 2025 results, with higher revenue, net income and earnings per share, alongside a reduced annual dividend of CHF 0.06 per share. See our latest analysis for HIAG Immobilien Holding. The earnings release and smaller dividend cut have arrived after a strong run in the shares, with a 30 day share price return of 7.62% and a 90...

Swiss Prime Site (SWX:SPSN) has drawn attention after announcing a CHF 350,000,000 private placement of senior unsecured convertible green bonds, a financing move that directly ties future equity dilution to bondholder conversion choices. See our latest analysis for Swiss Prime Site. Against this financing backdrop, Swiss Prime Site’s share price has risen to CHF143.2 with a 30 day share price return of 6.15% and a 90 day share price return of 22.18%. Its 1 year total shareholder return of...

Full year results and dividend decision set the tone for SFS Group stock SFS Group (SWX:SFSN) has been in focus after reporting full year 2025 results, with sales of CHF 3,045.4 million, net income of CHF 219 million, and a basic EPS of CHF 5.63. At the same time, the company confirmed an annual dividend of CHF 2.00 per share, with payment scheduled for April 30, 2026. This is a timeline many income focused investors will be watching closely. See our latest analysis for SFS Group. The latest...

COLTENE Holding (SWX:CLTN) has reported FY 2025 first half revenue of CHF118.1 million and basic EPS of CHF0.71, with the trailing twelve month figures sitting at CHF240.7 million of revenue and CHF2.39 of EPS. This gives investors an updated view on both top and bottom line performance. The company has seen revenue shift from CHF127.5 million with EPS of CHF1.74 in the first half of 2024 to CHF122.7 million and EPS of roughly CHF1.69 in the second half of 2024, before landing at the current...

Dividend announcement and key dates Plazza (SWX:PLAN) has announced an annual dividend of CHF 10.00 per share. The cash payment is scheduled for 9 April 2026, the ex-dividend date is 7 April, and the record date is 8 April. See our latest analysis for Plazza. Plazza's latest dividend move comes after a period of steadily positive momentum, with a 90 day share price return of 14.0% and a 1 year total shareholder return of 32.17% suggesting improving sentiment around both income and capital...

PSP Swiss Property (SWX:PSPN) has released its full-year 2025 results, reporting sales of CHF 349.23 million and net income of CHF 408.47 million, along with an annual dividend of CHF 3.95 per share. See our latest analysis for PSP Swiss Property. The full-year earnings and higher dividend announcement come after a strong run in the shares, with an 18.27% 90-day share price return and a 29.31% 1-year total shareholder return, suggesting momentum has been building recently. If this update has...

Why Zurich Insurance Group (SWX:ZURN) is back on investors’ radar Zurich Insurance Group (SWX:ZURN) has drawn fresh attention after reporting its highest-ever annual profit for 2025, supported by its U.S. Farmers Management Services business and a benign catastrophe year. The board has also proposed lifting the dividend to CHF 30 per share, a 7% increase, subject to shareholder approval, giving investors a fresh data point to reassess the stock. See our latest analysis for Zurich Insurance...

VZ Holding (SWX:VZN) is back in focus after reporting full year 2025 results, issuing 2026 guidance on revenue and net profit, and announcing an annual dividend of CHF 2.95 per share. See our latest analysis for VZ Holding. The recent combination of 2025 earnings, 2026 guidance and a higher dividend seems to be feeding into sentiment. The 1-day share price return of 1.50% and 7-day share price return of 2.76% contrast with a year-to-date share price return decline of 1.46% and a 3-year total...

Galderma Group (SWX:GALD) has just posted its FY 2025 results with first half revenue of US$2.5b and basic EPS of US$0.82, framing a year where trailing twelve month revenue reached about US$5.2b and EPS came in at US$2.60. The company has seen revenue move from US$2.2b and EPS of US$0.20 in the first half of 2024 to US$2.5b and EPS of US$0.82 in the first half of 2025, while trailing twelve month EPS stepped up from US$0.97 to US$2.60 over the same window. This sets up a story where...

Amrize (SWX:AMRZ) has introduced its new EVERtect™ high-performance concrete range for customers in North America. The portfolio includes multiple specialized mixes tailored for different construction uses across the U.S. and Canada. The launch expands Amrize’s presence in high-spec concrete solutions for both structural and low-carbon applications. For you as an investor, this move highlights how Amrize is positioning its core materials business around more differentiated, higher-spec...

If you are wondering whether ABB's current share price still makes sense after a strong run, this article breaks down what you are really paying for the business today. ABB shares last closed at CHF 67.20, with returns of 46.1% over 1 year and 181.5% over 5 years. The shorter term picture is mixed, with a 4.8% decline over 7 days but a 9.7% gain year to date. Recent headlines have focused on ABB's ongoing position as a major player in electrification and automation, as well as its exposure...

Alcon reports that more than 175 million of its intraocular lenses have been implanted worldwide. The milestone highlights broad adoption of the company’s presbyopia-correcting IOLs across global eye care practices. Alcon plans further intraocular lens launches, subject to regulatory approvals. For investors following Alcon (SWX:ALC), this update comes with the shares trading at CHF63.96 and a value score of 4. The stock shows a 22.3% decline over the past year, while 3-year and 5-year...

On 24 February 2026, Iconovo AB announced it had signed a Letter of Intent with Lonza Group to pursue a long-term collaboration around spray dried formulation capabilities for inhalable biologics, building on their existing work on an obesity project. This potential alliance links Lonza’s CDMO scale with Iconovo’s five-platform inhaler technology targeting biologics and high-value respiratory franchises with global turnover of about US$9.00 billion. We’ll now examine how this focus on spray...

Avolta AG recently completed the cancellation of about 4.9 million treasury shares, reducing its registered share capital to CHF 708,241,695 across 141,648,339 shares, while continuing to expand its food and beverage footprint at key airports in Italy and Canada. This combination of a tighter share base and integrated travel retail and dining growth highlights Avolta’s focus on capital efficiency alongside strengthening its airport partner relationships. Next, we’ll examine how Avolta’s...

Zurich Insurance Group has confirmed the acquisition of UK based insurer Beazley, following completion of an accelerated equity offering to fund the deal. The transaction expands Zurich's presence in international insurance markets and follows investor backing via fresh equity capital. The company, trading as SWX:ZURN, remains in focus as integration plans and capital impacts come into view for shareholders. Zurich Insurance Group, ticker SWX:ZURN, is approaching this deal with a current...

Sandoz Group (SWX:SDZ) has received EU marketing authorization for Ranluspec. The approval expands the company’s biosimilars portfolio into the ophthalmology segment. The decision supports an expected product launch later in 2026 across European markets. For you as an investor, this represents a business development in a high-value area of medicine. Sandoz focuses on biosimilars and generics, and Ranluspec adds another product aimed at chronic eye conditions where long-term treatment is...

Why the infant formula recalls matter for Nestlé (SWX:NESN) Nestlé (SWX:NESN) is under close watch after recalling infant formula products in more than 60 countries due to low levels of the cereulide toxin, prompting tighter safety controls and raising fresh questions for shareholders about risk and resilience. See our latest analysis for Nestlé. Despite concerns around the recalls, Nestlé’s recent 30 day share price return of 13.32% and year to date share price return of 8.86% contrast with...

dormakaba Holding (SWX:DOKA) moved into focus after its H1 2026 results, reporting sales of CHF 1,362.7 million and net income of CHF 40.5 million, both below the prior half year. See our latest analysis for dormakaba Holding. The H1 2026 earnings release helps explain why the 90 day share price return sits at a decline of 13.01%, even though the 3 year total shareholder return is a gain of 41.09% and recent momentum has weakened despite a 3.60% 1 day share price return to CHF57.5. If this...

Sulzer AG has reported its full-year 2025 results, with sales of CHF 3,555.4 million, net income of CHF 292.8 million, and record EBITDA of CHF 556 million, marking a third consecutive year of margin expansion despite currency and geopolitical pressures. An increased dividend, a higher-margin aftermarket business now contributing 62% of turnover, and record profitability across divisions highlight how Sulzer’s operational excellence and services focus are reshaping its earnings...